15-PGDH-IN-5
15-PGDH-IN-5 is a sulfoxide-based inhibitor of 15-hydroxyprostaglandin dehydrogenase (15-PGDH). 15-PGDH-IN-5 exhibits great water solubility, metabolic stability, and in vivo exposure levels. 15-PGDH-IN-5 blocks the 15-PGDH-mediated irreversible oxidative degradation of PGE2 and increases the effective concentration of endogenous PGE2 in tissues, thereby exerting anti-inflammatory effects and promoting tissue repair and regeneration. 15-PGDH-IN-5 is suitable for research into tissue injury and fibrosis-related diseases, such as inflammatory bowel disease and idiopathic pulmonary fibrosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1714984-32-3
- Formule: C19H21N5OS3
- Masse moléculaire:431.60
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
15-PGDH-IN-5 (compound 5) exhibits enhanced aqueous solubility and improved metabolic stability relative to SW033291[1].
15-PGDH-IN-5 elevates intracellular prostaglandin E2 (PGE2) levels by blocking the catabolism of PGE2, thereby potentiating tissue repair and regeneration processes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1714984-32-3
-
Masse moléculaire 431.60
-
Formule C19H21N5OS3
-
SMILES
NC1=C([S@+]([O-])CCCC)SC2=NC(C3=NC=CS3)=CC(C4=CN=C(C)N4C)=C12
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)